Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma

Blood. 2018 May 10;131(19):2138-2150. doi: 10.1182/blood-2017-09-808063. Epub 2018 Mar 8.

Abstract

Multiple myeloma (MM) is an aggressive cancer that originates from antibody-secreting plasma cells. Although genetically and transcriptionally well characterized, the aberrant gene regulatory networks that underpin this disease remain poorly understood. Here, we mapped regulatory elements, open chromatin, and transcription factor (TF) footprints in primary MM cells. In comparison with normal antibody-secreting cells, MM cells displayed consistent changes in enhancer activity that are connected to superenhancer (SE)-mediated deregulation of TF genes. MM cells also displayed widespread decompaction of heterochromatin that was associated with activation of regulatory elements and in a major subset of patients' deregulation of the cyclic adenosine monophosphate pathway. Finally, building SE-associated TF-based regulatory networks allowed identification of several novel TFs that are central to MM biology. Taken together, these findings significantly add to our understanding of the aberrant gene regulatory network that underpins MM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Cell Lineage / genetics
  • Chromatin / genetics*
  • Chromatin / metabolism
  • Chromatin Assembly and Disassembly*
  • Computational Biology / methods
  • Enhancer Elements, Genetic*
  • Gene Expression Regulation, Neoplastic*
  • Gene Regulatory Networks*
  • Humans
  • Immunophenotyping
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / metabolism
  • Translocation, Genetic

Substances

  • Biomarkers
  • Chromatin